Search Results 491-500 of 11374 for anti-TNF drugs

  1. Pexidartinib (oral route) - Side effects & dosage - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  2. Expanded Access Program With Nivolumab (BMS-936558) In Combination With Ipilimumab (Yervoy®) In Anti-CTLA-4 Treatment-Naïve Subjects With Unresectable Or Metastatic Melanoma (CheckMate 218) - Mayo Clinic

    Clinical Trials · Expanded Access Program With Nivolumab (BMS-936558) In Combination With Ipilimumab (Yervoy®) In Anti-CTLA-4 Treatment-Naïve Subjects With ...

  3. Drug-eluting stents: Do they increase heart attack risk? - Mayo Clinic

    Anti-platelet therapy for coronary stents. Mayo Clinic; 2019. Medical review (expert opinion). Mayo Clinic. May 8, 2026. Lawton JS, et al. 2021 ACC/AHA/SCAI ...

  4. A Study Using A New Drug, Nivolumab, In Combination With Chemotherapy Drugs To Treat A Type Of Cancer Called Nasopharyngeal Carcinoma (NPC) - Mayo Clinic

    About this study. This phase II trial tests how well nivolumab in combination with chemotherapy drugs along with radiation therapy works in treating ...

  5. A Study Of Vedolizumab In Children And Teenagers With Moderate To Severe Crohn's Disease (CD) - Mayo Clinic

    corticosteroids, immunomodulators (eg, AZA, 6-mercaptopurine, methotrexate), and/or TNF-α antagonist therapy (e.g., infliximab, adalimumab). This includes ...

  6. Clinical trials - Oncology (Medical)

    Anti-cancer activity will be assessed every 6 ... Drugs used in chemotherapy regimens such as UH-3 ... drugs for the initial WT) and regimen ICE ...

  7. Anti-VEGF Vs. Prompt Vitrectomy For VH From PDR - Mayo Clinic

    Intravitreous anti-vascular endothelial growth factor (anti-VEGF) therapy alone or vitrectomy combined with intraoperative PRP each provide the opportunity to ...

  8. A Study of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction - Mayo Clinic

    ... Anti-Platelet) agents. In addition to exploring ED treatment patterns and success of both ischemic and bleeding risk stratification prior to definition of ...

  9. Mesenteric Sparing for the Prevention of Recurrent Crohn's Disease - Mayo Clinic

    Concurrent therapies with corticosteroids, 5-ASA drugs, thiopurines, MTX, antibiotics, and anti-TNF therapy are permitted. All patients should have ...

  10. Mayo Clinic researchers study new class of drugs to treat multiple myeloma

    PHOENIX — Mayo Clinic researchers are studying a new class of immunotherapy drugs called "bispecific antibodies" that have demonstrated potent tumor-killing ...